Host-directed therapies for infectious diseases: current status, recent progress, and future prospects

A Zumla, M Rao, RS Wallis, SHE Kaufmann… - The Lancet Infectious …, 2016 - thelancet.com
Despite extensive global efforts in the fight against killer infectious diseases, they still cause
one in four deaths worldwide and are important causes of long-term functional disability …

Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs

A Ait-Ammar, A Kula, G Darcis, R Verdikt… - Frontiers in …, 2020 - frontiersin.org
One of the most explored therapeutic approaches aimed at eradicating HIV-1 reservoirs is
the “shock and kill” strategy which is based on HIV-1 reactivation in latently-infected cells …

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

OS Søgaard, ME Graversen, S Leth, R Olesen… - PLoS …, 2015 - journals.plos.org
Pharmacologically-induced activation of replication competent proviruses from latency in the
presence of antiretroviral treatment (ART) has been proposed as a step towards curing HIV …

Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

JH Elliott, F Wightman, A Solomon, K Ghneim… - PLoS …, 2014 - journals.plos.org
Human immunodeficiency virus (HIV) persistence in latently infected resting memory CD4+
T-cells is the major barrier to HIV cure. Cellular histone deacetylases (HDACs) are important …

Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation

L Shan, K Deng, NS Shroff, CM Durand, SA Rabi… - Immunity, 2012 - cell.com
Highly active antiretroviral therapy (HAART) suppresses HIV-1 replication but cannot
eliminate the virus because HIV-1 establishes latent infection. Interruption of HAART leads …

HIV latency

RF Siliciano, WC Greene - Cold Spring …, 2011 - perspectivesinmedicine.cshlp.org
HIV-1 can establish a state of latent infection at the level of individual T cells. Latently
infected cells are rare in vivo and appear to arise when activated CD4+ T cells, the major …

[HTML][HTML] Redefining the viral reservoirs that prevent HIV-1 eradication

E Eisele, RF Siliciano - Immunity, 2012 - cell.com
This Perspective proposes definitions for key terms in the field of HIV-1 latency and
eradication. In the context of eradication, a reservoir is a cell type that allows persistence of …

Zinc binding groups for histone deacetylase inhibitors

L Zhang, J Zhang, Q Jiang, L Zhang… - Journal of enzyme …, 2018 - Taylor & Francis
Zinc binding groups (ZBGs) play a crucial role in targeting histone deacetylase inhibitors
(HDACIs) to the active site of histone deacetylases (HDACs), thus determining the potency …

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

V Simon, DD Ho, QA Karim - The Lancet, 2006 - thelancet.com
The HIV-1 pandemic is a complex mix of diverse epidemics within and between countries
and regions of the world, and is undoubtedly the defining public-health crisis of our time …

Latency reversal and viral clearance to cure HIV-1

DM Margolis, JV Garcia, DJ Hazuda, BF Haynes - Science, 2016 - science.org
BACKGROUND A central challenge to emerging efforts to cure HIV infection is the
persistence of quiescent but replication-competent proviral genomes in resting CD4+ T …